U.S. Vaccines Market to Be Driven by High Demand for Pediatric Vaccines, to Reach US$17.4 Billion by 2018: Transparency Market Research

ALBANY, N.Y.--()--The vaccines market in the U.S. is studied at depth in a recent research report announced by Transparency Market Research. The report states that the U.S. vaccine market will grow at a CAGR of 5.3% between 2012 and 2018. The market, which valued US$12.8 billion in 2012, will reach US$17.4 billion by 2018. The report further indicates that the segment for human vaccines, leading the market by accounting for 80% shares in 2012, will continue to rule the U.S. market for vaccines.

Browse Report: http://www.transparencymarketresearch.com/us-vaccine-market.html

The report is titled “U.S. Vaccine Market (Human Vaccines: Hepatitis, Influenza, Meningococcal, Pneumococcal, HPV, Combination Vaccines; Animal Vaccines: Canine, Feline, Porcine, Bovine, Ovine, Poultry and Equine) - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020”.

Request Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=553

The report segments the U.S. vaccines market into human vaccines and animal vaccines. The segment of human vaccines is further divided into vaccine types and antigen. The segment of animal vaccines is further categorized according to types of target animals.

Press Release: http://www.transparencymarketresearch.com/pressrelease/us-vaccine-market.htm

Pediatric vaccines were the leading sub-segment of the human vaccine segment in 2012. The segment of pediatric vaccines currently has an impressive share of the market and holds good future prospects owing to government compulsion for immunizing children in the U.S.

Article: http://www.transparencymarketresearch.com/article/us-vaccine-market.htm

The market segment of livestock vaccines in animal vaccines leads the market and held a 58.1% share of the market in 2012. The market segment of bovines generated the largest amount of revenue for the market in the same year.

Key businesses producing human vaccines in the U.S. market include Sanofi-Pasture, GlaxoSmithKline, Pfizer, Merck, Novartis, and Sanofi-Aventis. Leading businesses producing animal vaccines include companies such as Merial (Sanofi-Aventis), Novartis Animal Health, Intervet/Schering-Plough (Merck) and Pfizer Animal Health.

Browse All Pharmaceuticals Research Reports: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About TMR

Transparency Market Research (TMR) is a U.S. based market intelligence company driven by high-pedigree consultants and researchers. TMR leverages its Syndicated Research, Custom Research, and Market Consulting expertise to help businesses make accurate decisions. TMR’s exclusive blend of quantitative forecasting and trends analysis draws on proprietary data sources and techniques, while their data repository is continuously updated to reflect the latest trends.

Contacts

Transparency Market Research
Mr. Nachiket Ghumare, +1 518-618-1030
USA-Canada Toll Free: 866-552-3453
sales@transparencymarketresearch.com
http://www.transparencymarketresearch.com/

Release Summary

U.S. Vaccine Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Contacts

Transparency Market Research
Mr. Nachiket Ghumare, +1 518-618-1030
USA-Canada Toll Free: 866-552-3453
sales@transparencymarketresearch.com
http://www.transparencymarketresearch.com/